Current News

Country:
Operation:
Search for:
Overview Companies Countries Top News Tag Clouds
All   Business   Career   Cooperation   Finances   Laws   Manufacturing   Market
People   Politics   Products   Research   Technology

Contact | Print version | PDF version | Send article | RSS-FeedRSS feed

Dalton Medicinal Chemistry Partners Achieves Another Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd.

28 Jan 2008 - Dalton Medicinal Chemistry Partners, the Medicinal Chemistry arm of Dalton Pharma Services, announced that it has achieved another targeted milestone in its Medicinal Chemistry agreement with Boehringer Ingelheim (Canada) Ltd.

 
Dalton Medicinal Chemistry Partners is utilizing their medicinal chemistry expertise to design and synthesize novel compounds against an antiviral target selected by Boehringer Ingelheim (Canada) Ltd. Peter Pekos, President of Dalton Pharma Services, said: "We are pleased to achieve this additional milestone in our exciting partnership with Boehringer Ingelheim (Canada) Ltd. It is a pleasure working with the talented team at BI."
 
Contact / Request Information
Additional information
MyBionity.COM
Newsletter Subscription
Your e-mail:
Top  
© 2001-2008 Chemie.DE Information Service GmbH
a Life Science Network Division

 www.Chemie.DE   www.Bionity.COM   www.ChemEurope.COM   www.ChemieKarriere.NET   www.BioKarriere.NET